Previous Article | Next Article ![]()
Applied and Environmental Microbiology, October 1998, p. 3939-3947, Vol. 64, No. 10
Department of
Microbiology,1
Department of Plant
Pathology,3 and
Complex Carbohydrate
Research Center,2 University of Georgia,
Athens, Georgia 30602
Received 26 March 1998/Accepted 29 May 1998
Genetic manipulation of fluorescent pseudomonads has provided major
insight into their production of antifungal molecules and their role in
biological control of plant disease. Burkholderia cepacia
also produces antifungal activities, but its biological control
activity is much less well characterized, in part due to difficulties
in applying genetic tools. Here we report genetic and biochemical
characterization of a soil isolate of B. cepacia relating
to its production of an unusual antibiotic that is very active against
a variety of soil fungi. Purification and preliminary structural
analyses suggest that this antibiotic (called AFC-BC11) is a novel
lipopeptide associated largely with the cell membrane. Analysis of
conditions for optimal production of AFC-BC11 indicated stringent
environmental regulation of its synthesis. Furthermore, we show that
production of AFC-BC11 is largely responsible for the ability of
B. cepacia BC11 to effectively control the damping-off of
cotton caused by the fungal pathogen Rhizoctonia solani in a gnotobiotic system. Using Tn5 mutagenesis, we identified,
cloned, and characterized a region of the genome of strain BC11 that is required for production of this antifungal metabolite. DNA sequence analysis suggested that this region encodes proteins directly involved
in the production of a nonribosomally synthesized lipopeptide.
Each year, fungal diseases cause
millions of dollars worth of crop damage all over the world despite the
extensive use of pesticides (11). Also, environmental
concerns and development of resistance in target populations have
reduced the availability of effective fungicides. Nonetheless, the vast
array of antimicrobial molecules produced by diverse soil microbes
remains as a reservoir of new and potentially safer biopesticides. For
these and other reasons, a heightened interest in so-called biological
control or biocontrol (i.e., the use of natural microorganisms or their products to limit attack and damage by phytopathogens) has arisen (2, 4, 19, 63, 65).
There are many well-documented cases (reviewed in references
19 and 65) where the efficacy of
a biological control microbe in the greenhouse and in the field depends
on the production of single or multiple fungal growth antagonists
(antifungal compounds [AFCs]). Many cases involve fluorescent
pseudomonads that produce antibiotics such as phenazines
(64), 2,4-diacetylphloroglucinol (12, 28),
pyrrolnitrin (21, 22), pyoluteorin (23, 36, 43),
or siderophores (10). Recently, gene clusters encoding biosynthetic pathways for many of these antibiotics have been cloned
and characterized (18, 21, 36, 44; reviewed in reference 63). Mutants overexpressing the
biosynthetic genes, and hence overproducing the AFCs, have shown
increased efficacy and potential in biological control (40,
57).
In contrast, much less work has been done with Burkholderia
(Pseudomonas) cepacia (3, 67), even
though B. cepacia is a ubiquitous soil organism (5,
38) and various strains have been reported to produce a large
variety of AFCs such as cepacin (49), altericidins
(32), pyrrolnitrin (26, 27), xylocandins (also called cepacidines) (6, 37, 46), and
siderophores (60). B. cepacia is one of the most
nutrionally diverse bacteria known (i.e., it can use >200 different
organic compounds as its carbon source [38]), a trait
that probably contributes to its ability to compete for root exudates
and very effectively colonize roots and the rhizosphere (5, 31,
47). Studies suggest that B. cepacia can be an
effective biocontrol agent for Pythium-induced damping
off and Aphanomyces-induced root rot of pea (30, 47, 48), Botrytis-induced gray mold of apple
(25), Rhizoctonia solani-induced root rot of
Poinsettia (7), and other fungal diseases
(13). However, in all these cases very little is known about
the genetics or biochemistry of the biocontrol ability of B. cepacia.
A major limitation for molecular studies of the biological control
ability of B. cepacia is that unlike many other
pseudomonads, tools for its genetic manipulation and analysis are much
less well developed, largely due to its inherently high levels of
resistance to many antibiotics and low frequencies of electroporation
and conjugative plasmid transfer. Furthermore, the B. cepacia genome is very large (>7 Mb), is composed of multiple
replicons, and contains a large number of insertion sequences,
resulting in extensive genomic and physiological variability and
heterogeneity (39). However, as we report here, it is
possible to apply some standard molecular genetic techniques to
B. cepacia, which, in conjunction with classical biochemical
approaches, can provide new insights into the physiology and ecology of
B. cepacia. We describe the discovery of a new antifungal
metabolite that inhibits the growth of numerous fungi. We also
demonstrate that this AFC (herein called AFC-BC11) is largely
responsible for the ability of B. cepacia BC11 to
effectively control a damping-off disease caused by R. solani. Purification and characterization of this AFC, as well as
analysis of several genes required for its biosynthesis, provided good
evidence that it is a novel lipopeptide antibiotic which is synthesized
nonribosomally.
Microorganisms, growth conditions, and media.
The bacterial
strains used in this study are listed in Table
1. B. cepacia was
routinely grown at 30°C on plates containing either nutrient agar
(Difco) supplemented with 0.5% glucose (NAG) or potato dextrose agar
(PDA [pH 5.6]; Difco). Escherichia coli was grown at
37°C in Luria-Bertani (LB) medium (42). BSM minimal medium
was prepared as described previously (54). Fungi were obtained from G. Michaels (Microbiology Department, University of
Georgia) and D. Sumner and R. Roncadori (Plant Pathology Department, University of Georgia) and cultured at 30°C on PDA plates.
Pseudomonas aeruginosa PAO1, Pseudomonas putida
ATCC 12633, and Acinetobacter calcoaceticus BND1 were from
our laboratory collection. The antibiotic levels used to select for
B. cepacia constructs were 350 µg/ml for kanamycin,
100 µg/ml for rifampin, and 200 µg/ml for tetracycline. The levels
used to select for E. coli constructs were 50 µg/ml for
kanamycin, 20 µg/ml for tetracycline, and 100 µg/ml for ampicillin.
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Characterization of Genes Involved in Biosynthesis of a Novel
Antibiotic from Burkholderia cepacia BC11 and Their Role
in Biological Control of Rhizoctonia solani
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
TABLE 1.
Bacterial strains and plasmids used in this study
Bioassay for AFC activity. Samples to be assayed were dried in a vacuum centrifuge, and the residue was dissolved in acidic methanol (85% methanol adjusted to pH 3 with concentrated HCl). Serial dilutions (1:3) were made in acidic methanol, and 10-µl aliquots were added to wells of 96-well-format microtiter dishes containing 0.3 ml of solidified PDA. After being dried for 30 min at 37°C, the wells were inoculated with 10 µl of a hyphal suspension of R. solani AG4 prepared by scraping aerial hyphae from a 4-day-old PDA plate culture with a loop and resuspending them in sterile water. After incubation for 2 to 3 days at 30°C, the greatest dilution giving complete growth inhibition was recorded and defined as containing 1 U of activity; 10 µl of acidic methanol alone had no observable effect on the growth of R. solani. For a qualitative assay of AFC production by growing cells, the hyphal suspension was spread onto PDA plates and dried for 15 min before being subjected to spot inoculation with a loopful of test bacteria. After 3 days at 30°C, the size of the fungal growth inhibition zone around each bacterial patch was used as a measure of AFC production.
Purification of AFC-BC11. A 5-ml volume of water containing 109 cells of B. cepacia BC11 was spread onto 500 ml of PDA in each of 10 disposable aluminum baking trays (40 by 25 cm). After 48 h at 30°C, the cells were scraped from the surface by using a glass plate spreader and 500 ml of water. Cells (ca 15 g [wet weight]) were collected by centrifugation and extracted twice by vigorous vortexing for 1 min with 50 ml of 80% acetone. Insoluble material was removed by centrifugation at 2,700 × g for 15 min and discarded. Acetone was evaporated with a stream of nitrogen at 50°C, and the remaining aqueous solution was centrifuged at 2,700 × g for 15 min. The pelleted insoluble material was washed with water three times and then dried in a vacuum centrifuge. The dried residue was extracted three times each with 50 ml of 100% acetone and then 1-butanol. After being dried, the residue was dissolved in 5 ml of dimethyl sulfoxide (DMSO) and applied to a C18 reverse-phase high-pressure liquid chromatography (HPLC) column (Z18TP54; Vydac Corp.). The column was eluted for 5 min with methanol-water-DMSO (50:45:5), after which the methanol concentration was increased to 75% over a 10-min period. Elution with methanol-water-DMSO (75:22:3) was continued until the AFC peak had completely eluted, usually after 10 to 20 min. Elution of BC11 AFC was monitored by measurement of the absorbance at 320 nm (A320) and/or bioassay.
Structural analyses of AFC-BC11.
Positive-mode fast atom
bombardment mass spectrometry (FAB-MS) was performed with a JEOL SX/SX
102A tandem mass spectrometer at an accelerating potential of 10 kV
(53). Equal volumes of sample and thioglycerol FAB matrix
were mixed on the probe tip and then bombarded with ions generated with
xenon and a JEOL FAB gun at 6 kV. The spectra consisted of averaged
profile data of three scans recorded by a JEOL XMS data system and
acquired from 200 to 2,000 m/z at a rate that would scan the
mass range from 0 to 2,500 in 1 min; the filtering rate was 100 Hz.
Matrix-assisted laser desorption ionization time-of-flight mass
spectrometry (MALDI-TOF MS) was performed on an LDI 1700XP spectrometer
at ~10
6 torr (accelerating voltage, 30 kV; extractor
voltage, 9 kV) (1, 53). A sample-2,4-dihydroxybenzoic acid
matrix mixture was serially vacuum dried on the probe and then ionized
with a nitrogen laser (
= 337 nm) by using a 3-ns, 6-mJ pulse.
Spectra were recorded from m/z 400 to 10,000 and are the
averages of ~150 acquisitions.
2.49.
Glycosyl composition analysis was performed by combined gas
chromatography-mass spectrometry of trimethylsilyl methyl glycosides
prepared by methanolysis and trimethylsilylation (Tri-Sil reagent;
Pierce Chemical). For amino acid analysis, the samples were hydrolyzed
in vacuo at 110°C for 20 h with HCl vapors. Released amino
acids were then converted to phenylthiocarbamyl amino acids
with phenylisothiocyanate in an ABI 420H derivatizer/130A
phenylthiocarbamyl analyzer. PTC amino acids were separated by HPLC on
a C18 silica column and quantified as specified by the
manufacturer.
Assay for biological control of R. solani-induced damping-off of cotton. Cotton seeds (Nucotin 35B) were immersed in 5% bleach for 10 min and then washed three times with sterile water. They were then immersed in bacterial suspensions of various concentrations (104 to 107 cells/ml) for 15 min and dried at 25°C for 30 min. The number of cells coating the seeds at each concentration was determined by vortexing portions of seed lots in sterile water and determining the number of viable cells in supernatants by dilution plating. Seed treatment with BC11 AFC was conducted by multiple applications of 10-µl aliquots of purified antibiotic dissolved at 0.3 mg/ml in methanol. After being dried, the seeds were planted in 9- by 8-cm pots containing R. solani-infested vermiculite (made by resuspending the aerial hyphae of a 5-day old PDA plate culture of R. solani in 50 ml of water and pouring the suspension onto the vermiculite). Disease development was monitored at 30°C for 3 weeks by scoring germination, seedling emergence, and survival.
Tn5 mutagenesis and screening for AFC-deficient
B. cepacia mutants.
E. coli SM10,
containing the Tn5 delivery plasmid pSUP2021
(58), and B. cepacia BC11R were grown to an
A600 of 0.5 by shaking in 18 ml of LB medium or
nutrient broth with 0.5% glucose (NBG), respectively. The cells were
washed twice with sterile water by centrifugation, resuspended in 0.3 ml of sterile water, and combined, and 30 0.02-ml aliquots were spotted
on NAG plates. After 24 h at 30°C, the cells were scraped up,
suspended in water, and adjusted to an A600 of
2, and 0.1-ml aliquots were spread on NAG plates plus kanamycin and
rifampin. After incubation at 37°C for 2 days, Kmr
Rifr colonies arose at a frequency of ~10
6
per donor. These were individually transferred into 96-well microtiter dishes filled with LB medium-7% glycerol-7% DMSO, incubated for 16 h at 37°C, and frozen at
80°C or transferred en masse
with a 96-well format replicator array to a large (15- by 150-mm) PDA plate previously spread with a suspension of R. solani
hyphae. After incubation for 2 to 3 days at 30°C, BC11 cells from
patches showing reduced fungal growth inhibition were picked and
purified to single colonies.
Cloning of genes involved in the production of BC11 AFC.
The
plasmids used are listed in Table 1; the physical and genetic maps of
some of these are shown in Fig. 1.
Genomic DNA from AFC666 (afc666::Tn5)
was isolated as described previously (54), digested with
EcoRI, ligated with EcoRI-digested pTZ19U (45), and transformed into E. coli DH5
. A
plasmid from one of the resultant Ampr Kmr
transformants was designated pKW666 and further characterized. pKW666-1 was constructed by digesting pKW666 with
BamHI, ligating under dilute conditions, and
transforming E. coli to Ampr. Analogously,
pKW666-1 was digested with PstI, ligated, and transformed into E. coli to obtain pKW666-2. pKW666-4 was
constructed by digesting pKW666-1 with HpaI and
BamHI, filling in cohesive ends with deoxynucleoside triphosphates (dNTPs) and Klenow polymerase, and ligating under dilute
conditions. pKW666-5 was constructed by ligating the 0.9-kb SalI fragment of pSB315 (containing nptI
[14]) into XhoI-digested pKW666-4. pT666-1
was constructed by ligating the 3.3-kb XbaI-EcoRI fragment of pKW666-5 into EcoRI- and
XbaI-digested pTOK2 (33). pR666 was constructed
by ligating the 2.2-kb StyI-EcoRI fragment of
pKW666-1 into EcoRI- and XbaI-digested pRK415
(29). pT666 was made by ligating a 10-kb EcoRI
fragment of pKW666 into EcoRI-digested pTOK2.
|
B. cepacia strain constructions.
Derivatives of pTOK2 and pRK415 were mobilized from E. coli DH5
into B. cepacia by triparental mating
with E. coli HB101 containing the helper plasmid
pRK2013 (9). B. cepacia AFC666M1 was
constructed by mobilizing the pTOK2 derivative pT666 into BC11R (a
spontaneous rifampin-resistant mutant of BC11); since pTOK2 is unable
to replicate in B. cepacia, selection for
Kmr, Rifr, and Tcs yields
allelic-exchange recombinants. Strain AFC666M2 was similarly constructed by transferring pT666-1 into BC11R and selecting
Kmr Rifr Tcs allelic-exchange
recombinants.
Recombinant DNA techniques and DNA sequence analysis.
Transformation of E. coli, restriction digests,
ligations, electrophoresis, and DNA isolation were performed by
standard methods as described previously (42, 54). Southern
blots were prepared and hybridized with DNA labeled by random priming
with [
-32P]dATP (42). Double-stranded
plasmid DNAs were sequenced with commercial and custom primers on an
ABI 380 sequencer. DNA sequence analysis and comparisons with sequences
contained in the GenBank and EMBL databases were performed with
Genetics Computer Group programs and the BLAST algorithm.
Nucleotide sequence accession number. The DNA sequence of the 4.5-kb B. cepacia genomic DNA on pKW666 (Fig. 1) has been deposited in GenBank under accession no. AF076477.
| |
RESULTS |
|---|
|
|
|---|
Characterization of AFC-BC11. Strain BC11 was isolated from agricultural soil in south Georgia and identified as B. cepacia by both fatty acid analysis and polyphasic taxonomic analysis (16). When grown on PDA plates next to R. solani, it produced a small, impenetrable growth inhibition zone. When fivefold-concentrated culture supernatants of BC11 were spotted on PDA plates, a similarly compact fungal growth inhibition zone was observed, suggesting limited aqueous solubility and diffusion. The levels of AFC activity found in preparations of filter-sterilized culture supernatants varied widely, but extraction of PDA-grown whole cells with 80% acetone consistently produced an organic-solvent-soluble cell-free preparation with high antifungal activity. When the cells were disrupted by sonication and centrifuged at 100,000 × g to yield a cytosolic fraction (supernatant) and membrane fraction (pellet), >80% of the AFC activity was found in the membrane fraction, suggesting that the AFC is lipophilic.
Preliminary experiments designed to find optimal growth conditions for AFC production revealed that its synthesis is stringently controlled. The AFC activity from cultures grown on PDA (initial pH, 5.5) plates for 3 days was 20 times higher than that from cultures grown for 24 h (580 and 30 U/109 cells, respectively), despite relatively minor differences in growth yields. If cells were grown for 3 days with shaking in 250-ml Erlenmeyer flasks containing 50 ml of potato dextrose broth (PDB), they usually contained <10% of the AFC activity of those grown on PDA plates (40 and 500 U/109 cells, respectively). However, if the cultures were grown in unshaken 250-ml flasks containing 50 ml of PDB, the AFC levels were at least ninefold higher than in identical shaken cultures (480 and 52 U/109 cells, respectively). AFC production by cells grown on BSM minimal-glucose plates at pH 7 or 8 was undetectable; in contrast, that of cells grown on analogous plates at pH 6 was 210 U/109 cells. These data suggest that acidic pH, low aeration, and/or growth on a surface to stationary phase are important conditions for maximal AFC production.Purification and structural analyses of AFC-BC11. A dried 80% acetone extract from 15 g of BC11 cells (58 mg) was sequentially extracted with various solvents (see Materials and Methods), removing 85% of the mass but only 10% of the AFC activity. Fractionation of the residue (8 mg) by HPLC gave a single peak of AFC activity that contained ca. half of the loaded mass. This purified AFC, like the AFC activity in concentrated culture supernatants, was reasonably soluble in DMSO, 80% acetone, or 70 to 95% methanol but poorly soluble in water, butanol, chloroform, or hexane. Similarly, it was also resistant to overnight treatment with protease or 30 min of treatment with 0.1 M acid or 0.1 M base or by boiling.
Analysis of the HPLC-purified AFC preparation by either FAB-MS or MALDI-TOF MS showed a single species with a molecular mass of 733. Proton NMR analysis gave three resonances between
6.4 and
7.2,
indicative of a conjugated double-bond system and consistent with the
results of UV-visible spectroscopy, which showed a single absorption
maximum for the AFC at 322 nm. A triplet was found at
0.85,
indicating aliphatic methyl protons. A broad resonance from
1.1 to
1.35 and others at
1.4 to
1.7 denote the presence of aliphatic
methylene protons, some on carbons adjacent to carbonyl and/or vinyl
carbons. A triplet at
5.3 is coupled to the methylene protons at
1.4 to
1.7, indicating protons of a cis double bond bordered by aliphatic methylene protons. In summary, the NMR results indicate that the AFC may contain an aromatic component and a fatty
acyl component with one double bond in a cis configuration.
Amino acid analysis of the purified AFC showed three major components,
possibly glycine, lysine, phenylalanine, and/or diaminobutyric acid,
suggesting that the AFC contains a peptide moiety. The cepacidines (also called xylocandins), a family of AFCs previously found in B. cepacia (6, 37, 46), contain similar
types of components. However, unlike the cepacidines, glycosyl
composition analysis of our AFC showed only trace levels of any
carbohydrate; moreover, the target specificity (see below) and
molecular mass of the AFC from BC11 dramatically differ from those of
any of the cepacidines. Therefore, we provisionally call this
potentially novel compound AFC-BC11, pending completion of definitive
structural determination.
Selectivity of AFC-BC11: determination of MICs for various fungi. Using the microtiter dish dilution assay, we quantified the potency (MICs) of purified AFC-BC11 against various fungi and bacteria. Concentrations of <1 µg/ml strongly inhibited the growth of some soil-borne phytopathogenic fungi, especially Pythium ultimum and Colletotrichium sp. (Table 2). In contrast, it had little effect on Candida albicans, several other yeasts, and some pathogenic and nonpathogenic filamentous fungi (Table 2). The sensitivity pattern of various fungi to growth inhibition by purified AFC-BC11 was identical to that exhibited by growing B. cepacia BC11 cells on PDA plates, suggesting that AFC-BC11 is a primary factor responsible for fungal growth inhibition by this bacterium on agar plates.
|
Efficacy of B. cepacia BC11 and AFC-BC11 in biological control of damping-off of cotton caused by R. solani. Cotton seeds were coated with various numbers of BC11 cells and then planted into vermiculite infested with R. solani. After 3 weeks, we found that as few as 100 BC11 cells per seed dramatically increased germination rates (Table 3). At 105 cells per seed, 100% survival and complete disease protection were observed. To evaluate the importance of AFC-BC11 in the observed biocontrol, different amounts of purified AFC-BC11 were applied to cotton seeds, which were subsequently planted into R. solani-infested vermiculite. As little as 5 µg of purified AFC-BC11 dramatically increased cotton seedling emergence and survival (Table 3). The disease control provided by 10 µg of AFC was the same as that provided by 104 BC11 cells. Taken together, these results show that B. cepacia BC11 can be very effective in controlling damping-off and imply that the AFC it produces is a primary determinant of its biological control ability.
|
Generation and characterization of AFC-deficient mutants of B. cepacia BC11. To confirm the primary importance of AFC-BC11 in biocontrol and gain insight into its biosynthesis, we isolated and characterized Tn5 insertion mutants defective in AFC-BC11 production. Matings between B. cepacia BC11R and E. coli SM10(pSUP2021) produced 2,000 putative Tn5 insertion mutants of B. cepacia, which were picked and replica plated onto PDA plates spread with R. solani hyphae. After 3 days, 20 mutants showed reduced fungal growth inhibition. However, after rigorous retesting, only four mutants (AFC143, AFC145, AFC202, and AFC666 [Table 1]) showed both a wild-type growth rate and a bona fide loss of ability to inhibit growth of R. solani. AFC activity in 80% acetone extracts of PDA-grown cells of all four mutants was less than 1% of that in extracts from wild-type cells. When extracts from mutants AFC202 and AFC666 were fractionated by HPLC, the major peak associated with AFC activity was missing (data not shown). Moreover, both extracts showed 10-fold less A322, the absorbance maximum of AFC-BC11. These results strongly suggested that these B. cepacia mutants have Tn5 inserted in genes required for production of AFC-BC11.
Southern analysis (42) of genomic DNA from the four mutants with the 3.3-kb HindIII fragment of Tn5 as a probe showed that the Tn5 insertion in three of the mutants (AFC202, AFC145, and AFC143) was apparently in the same region of the genome, because they all showed the same sizes of hybridizing EcoRI and SmaI fragments (data not shown). Moreover, all the mutants appeared to have only a single Tn5 insertion, since only one EcoRI fragment hybridized, a 10-kb fragment for AFC666 and a 6-kb fragment for the others. Since AFC202 and AFC666 showed different sizes of hybridizing fragments when EcoRI-, BamHI-, KpnI-, or SmaI-digested genomic DNA was used, we selected them as unique for further analysis. To confirm that biocontrol of R. solani depends strongly on production of AFC-BC11, 106 cells of the AFC-deficient BC11 mutants AFC202 and AFC666 were applied to cotton seeds and their biocontrol activity was compared to that of the wild type (Table 4). Both mutants had completely lost their ability to protect cotton seeds and seedlings from R. solani, even though we used >10-fold more cells than the minimum number of the wild-type cells needed for full control. Although these results strongly suggest that B. cepacia must produce AFC-BC11 for effective biological control, reduced soil survival or root colonization by the afc::Tn5 mutants could exaggerate the effect. To rule this out, a mixture of equal amounts of wild-type and AFC666 cells was inoculated onto cotton seeds, which were then planted in clean vermiculite. When the bacteria were isolated from the roots of seedlings 4, 8, and 12 days later, no significant change in the ratio of the two strains was observed, suggesting that AFC deficiency does not dramatically affect the ability of BC11 to colonize cotton roots in vermiculite. These data further support the claim that AFC-BC11 production is a primary determinant of biological control by B. cepacia BC11.
|
Cloning of genes involved in biosynthesis of AFC-BC11. In previous genetic studies of biocontrol bacteria, DNA sequence analysis of cloned genomic regions harboring Tn5 insertions that reduce the biocontrol activity has helped elucidate AFC biosynthetic pathways and their regulation (65). Thus, we cloned the EcoRI fragment of the AFC666 genome that had Tn5 inserted into an AFC-BC11 production gene. Plasmid DNA from a Kmr transformant (designated pKW666) harbored a 10-kb insert whose restriction endonuclease cleavage map indicated that it contained a 4.5-kb genomic DNA fragment with Tn5 inserted 1.5 kb from one end (Fig. 1).
To confirm that the cloned fragment harbored sequences involved in AFC-BC11 synthesis, we recloned it into the Tcr suicide plasmid pTOK2 (49) to produce pT666. Triparental mating of E. coli(pT666) with B. cepacia BC11R followed by selection for the Kmr Tcs phenotype produced allelic exchange recombinants of B. cepacia at a frequency of 10
9 per donor. No AFC activity was
detected when 80% acetone extracts of cells from four colonies were
bioassayed for AFC, confirming that they were probably marker exchanged
double-crossover afc::Tn5 mutants and
that pKW666 contains genes involved in AFC production. Analogous
results were obtained with genomic DNA cloned from AFC202; characterization of a cloned afc::Tn5
fragment from AFC202 will be reported elsewhere.
DNA sequence analysis of a genomic region involved in AFC
production.
The nucleotide sequence of the 4.5-kb genomic DNA on
pKW666 was determined. Based on analysis of codon usage, putative
ribosome-binding sites (RBS), and BLAST searches, four genes
(afcA, afcB, afcC, and
afcD) containing three complete and one partial open reading frame (ORF) were tentatively identified (Fig. 1). afcA and
afcB appeared to be transcribed from one strand, while
afcC and afcD were seemingly transcribed from the
other. The ca. 200-bp intergenic region between afcA and
afcC did not appear to contain an ORF and had a G+C content
20% lower than that of the flanking coding regions. Further inspection
identified a putative divergent promoter region having two very similar
sets of
35 and
10 consensus sequences separated by 150 bp (Fig.
1B). In fact, the DNA sequence upstream of the two putative
35
sequences showed extensive (60%) dyad symmetry centered around
position 2130, suggesting that it may have arisen by duplication.
|
-3 fatty acid desaturases, a family
of plant enzymes that introduce a double bond into 18:3 fatty acids
(68) (Fig. 2B). The homologous regions contain several
histidine box motifs proposed to be metal ion-binding sites involved in
the activities of these enzymes (68). Following AfcC
(starting with ATG at position 893) is the 283-residue AfcD ORF.
Residues 64 to 88 and 139 to 182 of this ORF show ca 35% amino
sequence identity to segments of several plant stearoyl acyl carrier
protein desaturases, enzymes that introduce a double bond at the
9 position of a C18 fatty acyl chain
(59). Interestingly, NMR analysis of AFC-BC11 suggests that
it contains an unsaturated fatty acyl chain with at least one
cis double bond. Moreover, the AFC-deficient strain AFC666
has Tn5 inserted in afcC, further implicating
AfcC and/or AfcD as potential desaturases involved in biosynthesis of
AFC-BC11.
Overlapping the afcA stop codon is the beginning of a fourth
putative ORF, afcB; it begins with an ATG at position 4044, is preceded by a good RBS, and extends beyond the end of the cloned genomic fragment. Residues 40 to 70 of this 93-residue partial ORF show
very strong amino acid sequence identity to a conserved region of PotG,
a membrane-bound putrescine transport protein of E. coli (50) and a glutamine transporter of
Methanococcus. The homologous region harbors the very
highly conserved ATP-binding site motif (P-loop signature
sequence) found in all members of the ATP-binding cassette
transporter superfamily (20), especially the one found in
amino acid transporters (reference 34a and results not shown).
Evidence for a direct role of the afc gene cluster in
AFC-BC11 production.
In strain AFC666, Tn5 is in
afcC, suggesting a role for the putative AfcC desaturase in
AFC production, but possible polar effects by Tn5 complicate
the interpretation. Based on its sequence homology to enzymes involved
in synthesis of peptide antibiotics, it is plausible that AfcA is
involved in synthesis of a peptide moiety of AFC-BC11. To directly
assess this possibility, we inserted a nonpolar nptI
cartridge (14) into the single XhoI site of afcA and in the same transcriptional orientation (Fig. 1).
The resultant afcA::nptI fragment was
recloned into the pTOK2 suicide vector, and the resultant plasmid
(pT666-1) was transferred into BC11R by conjugative mobilization.
Double-crossover marker-exchanged recombinants were selected by their
Kmr Tcs phenotype and arose at a frequency of
10
9 per donor. Bioassay of 80% acetone extracts of cells
from four such mutants (e.g., AFC666M2 [Table 1]) showed that they
produced >300-fold-reduced levels of AFC-BC11 (data not shown). When
afcA alone (i.e., the StyI-EcoRI
fragment of pKW666-1) was cloned downstream of the lac
promoter of pRK415 and the resultant plasmid (pR666 [Fig. 1]) was
transferred into the afcA::nptI BC11
mutant, AFC production was increased >40-fold, arguing against strong
polar effects by the nptI insertion. These results prove
that AfcA is directly involved in the biosynthesis of AFC-BC11.
| |
DISCUSSION |
|---|
|
|
|---|
We previously screened 15 different soil isolates with biocontrol potential for consistent production of extracellular AFCs and amenability to genetic manipulation (56). One promising strain, B. cepacia BC11, strongly inhibited the growth of R. solani and Sclerotium rolfsii in artificial soils and, in later field tests, appeared to enhance the yield of peanuts (55). However, the inconsistency of the performance of BC11, and biocontrol systems in general (19, 65), prompted us to seek a more detailed understanding of B. cepacia BC11 and its production of AFCs. We found that the major antifungal antibiotic activity of BC11 resided in a relatively insoluble, membrane-associated compound, although sometimes it was detected in the culture supernatant. After purification of this AFC by differential solvent extraction and reverse-phase HPLC, MS analysis showed that it had a molecular mass of 733 Da. NMR suggested that it contains an aromatic component and a fatty acyl substituent with a cis double bond. Analysis of acid hydrolysates detected four amino acids, suggesting the presence of a peptide moiety. These characteristics imply that this AFC produced by B. cepacia BC11 (called AFC-BC11) is a lipopeptide different from most other previously purified and structurally characterized antibiotics from biocontrol pseudomonads (19, 65). While some of its characteristics are reminiscent of members of the cepacidine (xylocandin) family of lipopeptide antibiotics from some B. cepacia strains (6, 37, 46), AFC-BC11 is much smaller (733 versus 1100 Da) and lacks xylose. Moreover, cepacidines are very active against Candida spp., Saccharomyces cerevesiae, Aspergillus niger, and several other fungal dermatophytes whereas AFC-BC11 was not (Table 2). Nonetheless, AFC-BC11 was very active against many other fungi, most of which were soil isolates and plant pathogens. The in vitro growth of many fungi was completely inhibited by as little as 1 µg/ml, similar to the potency of amphotericin B (37), pyrrolnitrin (22), and pyoluteorin (23) but more potent than at least one phenazine derivative (64).
Production of a potent AFC does not always guarantee good biological control performance (35, 43). However, with B. cepacia BC11, we found that in the presence of R. solani as few as 104 cells (or 5 µg of purified AFC-BC11) per seed increased the germination and survival rates of cotton seedlings from 0 to >50%. In comparison to what has been reported for many biocontrol strains (21, 23, 30, 35, 40, 43, 57), the minimum number of BC11 cells per seed required for full disease control is 2 orders of magnitude lower than that for most strains. However, unlike some other tests, our biocontrol assays were not done in natural soils, and so the efficacy of BC11 relative to other strains remains to be clarified.
Using Tn5 tagging, we isolated a genomic fragment encoding proteins essential for biological control by B. cepacia BC11. DNA sequence analysis of this fragment provided insight into the structure and biosynthesis of AFC-BC11. Part of the putative amino acid sequence of the product of one of the resident ORFs, AfcA, showed high similarity to a domain conserved in proteins which use ATP to convert amino acids into aminoacyl adenylates (34, 61), in particular to the amino acid activation domains of two large multifunctional peptide synthetases, SafB1 (51, 52) and SnbC (8, 62), that are involved in nonribosomal peptide synthesis of the antibiotics saframycin (M. xanthus) and pristinamycin (S. pristinaespiralis). However, AfcA is much smaller than peptide synthetases, since it has only one activation domain instead of the more typical three or four and lacks domains for elongation and attachment of the 4-phosphopantetheinyl arm (62). This architecture is reminiscent of SnbA, the 3-OH picolinic acid:AMP ligase that catalyzes the adenylation and activation of 3-OH picolinic acid during the synthesis of pristinamycin but does not subsequently bind it as a thioester. Instead, SnbA is thought to "deliver" activated 3-OH picolinic acid to a peptide synthetase for incorporation into pristinamycin (8, 62). Since AfcA shows such high homology to these amino acid activation domains and since a nonpolar insertion of nptI in afcA completely knocked out AFC production, it is plausible that AfcA activates an amino acid before its incorporation into a nonribosomally synthesized peptide component of AFC-BC11, consistent with physiochemical data suggesting that AFC-BC11 is a lipopeptide.
Unlike most other reports about B. cepacia, we were able to use reverse genetics to confirm the function of a cloned DNA sequence in a physiological process. Insertion of a nonpolar nptI cartridge into the genomic copy of afcA of B. cepacia BC11 completely eliminated the production of AFC-BC11, the ability to inhibit growth of R. solani in vitro, and the biocontrol activity. These data strongly suggest that BC11 produces only one major AFC that is a primary determinant of its biocontrol ability for R. solani-induced damping-off of cotton. This is in contrast to many other biological control pseudomonads, which commonly produce multiple AFCs that additively contribute to their biocontrol activity (65).
Although we did not unambiguously demonstrate a role in biosynthesis of AFC-BC11 for the two other complete ORFs on the cloned fragment, the fact that the initial Tn5-generated AFC-deficient mutant AFC666 had Tn5 inserted in afcC implies that one or both of these genes are required for AFC-BC11 biosynthesis. However, potential polar effects on downstream genes could also cause AFC deficiency. On the other hand, the similarity of the predicted amino acid sequences of segments of AfcC and AfcD to domains of desaturase enzymes which introduce cis double bonds into aliphatic chains (68), coupled with our NMR data indicating the presence of an acyl substituent with a cis double bond in AFC-BC11, further argues for a direct role for AfcC and/or AfcD in the biosynthesis of AFC-BC11. Genetic and biochemical experiments to confirm this are in progress.
For more effective field use of biocontrol microbes, we need a clearer knowledge of the field conditions that affect the biosynthesis of AFCs and hence biocontrol. The availability of cloned AFC-BC11 biosynthetic genes should allow the construction of reporter strains to study in situ rhizosphere conditions that increase expression of the biosynthetic genes and possibly the consistency of biocontrol. This type of approach has already been proven to be valuable (15, 36). Alternatively, addition of cloned AFC-BC11 biosynthetic genes to other biocontrol strains could lead to improved biocontrol agents (12, 17, 40, 57).
| |
ACKNOWLEDGMENTS |
|---|
This research was supported in part by a grant from the Biotechnology Program of the University of Georgia Research Foundation and the Georgia Commodity Commission for Peanuts. Support for instrumentation used in structural analysis was provided to the Complex Carbohydrate Research Center by Department of Energy Center grant DE-FG09-93ER20097.
We thank Tim Denny and Mark Wise for critical comments on the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, Biological Sciences Bldg., University of Georgia, Athens, GA 30602; Phone: (706) 542-0512. Fax: (706) 542-2674. E-mail: Schell{at}arches.uga.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | An, J., R. W. Carlson, J. Glushka, and J. G. Streeter. 1994. Structure of a novel polysaccharide produced by Bradyrhizobium within soybean nodules. Carbohydr. Res. 269:303-317. |
| 2. | Andrews, J. H. 1992. Biological control in the phyllosphere. Annu. Rev. Phytopathol. 30:603-635. [Medline] |
| 3. |
Ballard, R. W.,
N. J. Palleroni,
M. Doudoroff, and R. Y. Stanier.
1970.
Taxonomy of the aerobic Pseudomonads: P. cepacia, P. marginata, P. alliicola and P. caryophylli.
J. Gen. Microbiol.
60:199-214 |
| 4. |
Becker, J. O., and F. J. Schwinn.
1993.
Control of soil borne pathogens with living bacteria and fungi status and outlook.
Pestic. Sci.
37:355-363.
|
| 5. |
Bevivino, A.,
S. Tabacchioni,
L. Chiarini,
M. Y. Caruri,
M. Del Gallo, and P. Visca.
1994.
Phenotypic comparison between rhizosphere and clinical isolates of Burkholderia cepacia.
Microbiology
140:1069-1077 |
| 6. | Bisacchi, G. S., D. R. Hockstein, W. H. Koster, W. Parker, M. L. Rathnum, and S. E. Unger. 1987. Xylocandin: a new complex of antifungal peptides. II. Structural studies and chemical modifications. J. Antibiot. 40:1520-1529[Medline]. |
| 7. | Cartwright, D. K., and M. D. Benson. February 1994. Pseudomonas cepacia strain 5.5B and method of controlling Rhizoctonia solani therewith. U.S. patent 5,288,633. |
| 8. |
Crecy-Lagard, V.,
V. Blanc,
P. Gil,
L. Naudin,
S. Lorenzon,
A. Famechon,
N. Bamas-Jacques,
J. Crouzet, and D. Thibaut.
1997.
Pristinamycin I biosynthesis in Streptomyces pristinaespiralis: molecular characterization of the first two structural peptide synthetase genes.
J. Bacteriol.
179:705-713 |
| 9. |
Ditta, G.,
S. Stanfield,
D. Corbin, and D. R. Helinski.
1980.
Broad host range DNA cloning system for gram-negative bacteria: construction of a gene bank of Rhizobium meliloti.
Proc. Natl. Acad. Sci. USA
77:7347-7351 |
| 10. | Dowling, D. N., and F. O'Gara. 1994. Metabolites of Pseudomonas involved in the biocontrol of plant disease. Trends Biotechnol. 12:133-141. |
| 11. | Farr, D. F., G. F. Bills, G. P. Chamuris, and A. Y. Rossman. 1989. Fungi on plants and plant products in the United States. American Phytopathological Society, St. Paul, Minn. |
| 12. |
Fenton, A. M.,
P. M. Stephens,
J. Crowley,
M. O'Callaghan, and F. O'Gara.
1992.
Exploitation of gene(s) involved in 2,4-diacetylphloroglucinol biosynthesis to confer a new biocontrol capability to a Pseudomonas strain.
Appl. Environ. Microbiol.
58:3873-3878 |
| 13. |
Fridlender, M.,
J. Inbar, and I. Chet.
1993.
Biological control of soilborne plant pathogens by a -1,3 glucanase-producing Pseudomonas cepacia.
Soil Biol. Biochem.
25:1121-1221.
|
| 14. |
Galan, J. E.,
C. Ginocchio, and P. Costeas.
1992.
Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family.
J. Bacteriol.
174:4338-4349 |
| 15. |
Georgakopoulos, D. G.,
M. Henderson,
N. J. Panopoulos, and M. N. Schroth.
1994.
Analysis of expression of a phenazine biosynthesis locus of Pseudomonas aureofaciens PG12 on seeds with a mutant carrying a phenazine biosynthesis locus-ice nucleation reporter gene fusion.
Appl. Environ. Microbiol.
60:4573-4579 |
| 16. | Gitaitis, R., and D. Sumner. Unpublished results. |
| 17. | Gutterson, N. C. 1990. Microbial fungicides: recent approaches to elucidating mechanisms. Crit. Rev. Biotechnol. 10:69-91. |
| 18. | Hammer, P. E., D. S. Hill, S. Lam, K. VanPee, and J. Ligon. 1997. Four genes from the genome of Pseudomonas fluorescens that encodes the biosynthesis of pyrrolnitrin. Appl. Environ. Microbiol. 63:2147-2154[Abstract]. |
| 19. | Handelsman, J., and E. V. Stabb. 1996. Biocontrol of soilborne plant pathogens. Plant Cell 8:1855-1869[Medline]. |
| 20. | Higgins, C. F. 1992. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8:67-113. |
| 21. |
Hill, D. S.,
J. I. Stein,
N. R. Torkewitz,
A. M. Morse,
C. R. Howell,
J. P. Pachlatko,
J. O. Becker, and J. M. Ligon.
1994.
Cloning of genes involved in the synthesis of pyrrolnitrin from Pseudomonas fluorescens and role of pyrrolnitrin synthesis in biological control of plant disease.
Appl. Environ. Microbiol.
60:78-85 |
| 22. | Howell, C. R., and R. D. Stipanovic. 1979. Control of Rhizoctonia solani on cotton seedlings with Pseudomonas fluorescens with an antibiotic produced by the bacterium. Phytopathology 69:480-482. |
| 23. | Howell, C. R., and R. D. Stipanovic. 1980. Suppression of Pythium ultimum-induced damping-off of cotton seedlings by Pseudomonas fluorescens Pf-5 and its antibiotic, pyoluteorin. Phytopathology 70:712-715. |
| 24. | Howie, W. J., and T. Suslow. 1991. Role of antibiotic synthesis in the inhibition of Pythium ultimum in the cotton spermosphere and rhizosphere by Pseudomonas fluorescens. Mol. Plant-Microbe Interact. 4:393-399. |
| 25. | Janisiewicz, W. J., and J. Roitman. 1988. Biological control of blue mold and gray mold on apple and pear with Pseudomonas cepacia. Phytopathology 78:1679-1700. |
| 26. | Jayaswal, R. K., M. F. Fernandez, L. Visintin, and R. S. Upadhyay. 1992. Transposon Tn5-259 mutagenesis of Pseudomonas cepacia to isolate mutants deficient in antifungal activity. Can. J. Microbiol. 38:309-312[Medline]. |
| 27. | Jayaswal, R. K., M. Fernandez, R. S. Upadhyay, L. Visintin, M. Kurz, J. Webb, and K. Rinehart. 1993. Antagonism of Pseudomonas cepacia against phytopathogenic fungi. Curr. Microbiol. 26:17-22[Medline]. |
| 28. | Keel, C., U. Schnider, M. Maurhofer, C. Voisard, J. Laville, U. Burger, P. Wirthner, D. Haas, and G. Defago. 1992. Suppression of root diseases by Pseudomonas fluorescens CHA0: importance of the bacterial secondary metabolite 2,4-diacetylphloroglucinol. Mol. Plant-Microbe Interact. 5:4-13. |
| 29. | Keen, N. T., S. Tamaki, D. Kobayashi, and D. Trollinger. 1988. Improved broad-host-range plasmids for DNA cloning in Gram-negative bacteria. Gene 70:191-197[Medline]. |
| 30. | King, E. B., and J. L. Parke. 1993. Biocontrol of Aphanomyces root rot and Pythium damping-off by Pseudomonas cepacia AMMD on four pea cultivars. Plant Dis. 77:1185-1188. |
| 31. | King, E. B., and J. L. Parke. 1996. Population density of the biocontrol agent Burkholderia cepacia ammdr1 on four pea cultivars. Soil Biol. Biochem. 28:307-312. |
| 32. | Kirinuki, T., K. Iwanuma, N. Suzuki, H. Fukami, and T. Ueno. 1977. Altericidins, a complex of polypeptide antibiotics produced by Pseudomonas sp. and their effect for the control of black spot of pear caused by Alternaria Kikuchiana Tanaka. Sci. Rep. Fac. Agric. Kobe Univ. 12:223-230. |
| 33. |
Kitten, T., and D. K. Willis.
1996.
Suppression of a sensor kinase-dependent phenotype in Pseudomonas syringae by ribosomal proteins L35 and L20.
J. Bacteriol.
178:1548-1555 |
| 34. | Kleinkauf, H., and H. Von Dohren. 1990. Nonribosomal biosynthesis of peptide antibiotics. Eur. J. Biochemistry 192:1-15[Medline]. |
| 34a. | Koonin, E. Personal communication. |
| 35. | Kraus, J., and J. E. Loper. 1992. Lack of evidence for a role of antifungal metabolite production by Pseudomonas fluorescens Pf-5 in biological control of Pythium damping-off of cucumber. Phytopathology 82:264-271. |
| 36. | Kraus, J., and J. E. Loper. 1995. Characterization of a genomic region required for production of the antibiotic pyoluteorin by the biological control agent Pseudomonas fluorescens Pf-5. Appl. Environ. Microbiol. 61:849-854[Abstract]. |
| 37. | Lee, C., S. Kim, B. Hyun, J. Suh, C. Yon, C. Kim, Y. Lim, and C. Kim. 1994. Cepacidine A, a novel antifungal antibiotic produced by Pseudomonas cepacia. J. Antibiot. 47:1402-1418[Medline]. |
| 38. | Lessie, T. G., and T. Gaffney. 1986. Catabolic potential of Pseudomonas cepacia, p. 439-481. In J. R. Sokatch, and L. N. Ornston (ed.), The bacteria: a treatise on structure and function, vol. X. The biology of Pseudomonas. Academic Press, Inc., New York, N.Y. |
| 39. | Lessie, T. G., W. Hendrickson, B. Manning, and R. Devereux. 1996. Genomic complexity and plasticity of Burkholderia cepacia. FEMS Microbiol. Lett. 144:117-128[Medline]. |
| 40. | Ligon, J., S. Lam, T. Gaffney, S. Hill, R. Hammer, and N. Torkewitz. 1996. Biocontrol: modifications for enhanced antifungal activity, p. 457-462. In G. Stacey, B. Mullin, and P. Gresshoff (ed.), Biology of plant-microbe interactions. International Society for Molecular Plant-Microbe Interactions, St. Paul, Minn. |
| 41. | Ludwig, W., R. Rossello-Mora, R. Aznar, S. Klugbauer, S. Spring, K. Reetz, C. Beimfohr, E. Brockmann, G. Kirchhof, S. Dorn, M. Bachleitner, N. Klugbauer, N. Springer, D. Lane, R. Nietupsky, M. Weizenegger, and K. H. Schleifer. 1995. Comparative sequence analysis of 23S rRNA from proteobacteria. Syst. Appl. Microbiol. 18:164-188. |
| 42. | Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 43. | Maurhofer, M., C. Keel, U. Schinder, C. Voisard, D. Haas, and G. Defago. 1992. Influence of enhanced antibiotic production in Pseudomonas fluorescens strain CHA0 on its disease suppressive capacity. Phytopathology 82:190-195. |
| 44. | Mavrodi, D. V., V. Ksenzenko, B. Chatuev, L. S. Thomashow, and A. M. Boronin. 1997. Structural and functional organization of Pseudomonas fluorescens genes encoding enzymes of phenazine-1-carboxylic acid biosynthesis. Mol. Biol. 31:62-68. |
| 45. |
Mead, D. A.,
E. S. Skorupa, and B. Kemper.
1985.
Single stranded DNA promoter plasmids for engineering mutant RNA's and protein: synthesis of a 'stretched' parathyroid hormone.
Nucleic Acids Res.
13:1103-1108 |
| 46. | Meyers, E., G. S. Bisacchi, L. Dean, W. C. Liu, B. Minassian, D. S. Slusarchyk, R. B. Sykes, S. K. Tanaka, and W. Trejo. 1987. Xylocandin: a new complex of antifungal peptides. I. Taxonomy, isolation, and biological activity. J. Antibiot. 40:1515-1529[Medline]. |
| 47. | Parke, J. L. 1990. Population dynamics of Pseudomonas cepacia in the pea spermosphere in relation to biocontrol of Pythium. Phytopathology 80:1307-1311. |
| 48. | Parke, J. L., R. Rand, A. Joy, and E. B. King. 1991. Biological control of Pythium-damping off and Aphanomyces root rot of peas by application of Pseudomonas cepacia or Pseudomonas fluorescens to seed. Plant Dis. 75:987-992. |
| 49. | Parker, W. L., M. L. Rathnum, V. Seiner, W. H. Trejo, P. A. Principe, and R. B. Sykes. 1984. Cepacin A and cepacin B, two new antibiotics produced by Pseudomonas cepacia. J. Antibiot. 37:431-440[Medline]. |
| 50. |
Pistocchi, R.,
K. Kashiwagi,
S. Miyamoto,
E. Nukui,
Y. Sadakata,
H. Kobyashi, and K. Igarashi.
1993.
Characteristics of the operon for a putrescine transport system that maps at 19 minutes of the Escherichia coli chromosome.
J. Biol. Chem.
268:146-152 |
| 51. |
Posiech, A.,
B. Cruzel,
J. Bietenhader, and T. Schupp.
1995.
A new Myxococcus xanthus gene cluster for the biosynthesis of the antibiotic saframycin Mx1 encoding a peptide synthetase.
Microbiology
141:1793-1803 |
| 52. |
Posiech, A.,
J. Bietenhader, and T. Schupp.
1996.
Two multifunctional peptide synthetases and an O-methyltransferase are involved in the biosynthesis of the DNA-binding antibiotic and antitumour agent saframycin Mx1 from Myxococcus xanthus.
Microbiology
142:741-746 |
| 53. | Rhaman, M., J. Guard-Petter, K. Asokan, and R. W. Carlson. 1997. The structure of the capsular polysaccharide from a swarming strain of pathogenic Proteus vulgaris. Carbohydr. Res. 301:213-220[Medline]. |
| 54. | Roberts, D. P., T. P. Denny, and M. A. Schell. 1987. Cloning of the egl gene of Pseudomonas solanacearum and analysis of its role in phytopathogenicity. J. Bacteriol. 170:1445-1451. |
| 55. | Schell, M., and T. Brenneman. 1992. Unpublished observations. |
| 56. | Schell, M., and Y. Kang. 1996. Unpublished observations. |
| 57. |
Schinder, U.,
C. Keel,
C. Blumer,
J. Troxler,
G. Defago, and D. Haas.
1995.
Amplication of the housekeeping sigma factor in Pseudomonas fluorescens CHA0 enhances antibiotic production and improves biocontrol abilities.
J. Bacteriol.
177:5387-5392 |
| 58. | Simon, R., U. Priefer, and A. Puhler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Bio/Technology 1:784-791. |
| 59. | Slocombe, S., I. Cummins, R. Jarvis, and D. J. Murphy. 1992. Nucleotide sequence and temporal regulation of a seed-specific Brassica napus cDNA encoding a stearoyl-acyl carrier protein (ACP) desaturase. Plant Mol. Biol. 20:151-155[Medline]. |
| 60. |
Sokol, P. A.,
C. J. Lewis, and J. J. Dennis.
1992.
Isolation of a novel siderophore from Pseudomonas cepacia.
J. Med. Microbiol.
36:184-189 |
| 61. | Stachelhaus, T., and M. A. Marahiel. 1995. Modular structure of genes encoding multifunctional peptide synthetases required for non-ribosomal peptide synthesis. FEMS Microbiol. Lett. 125:3-14[Medline]. |
| 62. |
Thibaut, D.,
D. Bisch,
N. Ratet,
L. Maton,
M. Couder,
L. Debussche, and F. Blanche.
1997.
Purification of peptide synthetases involved in pristinamycin I biosynthesis.
J. Bacteriol.
179:697-704 |
| 63. | Thomashow, L. S. 1996. Biological-control of plant-root pathogens. Curr. Opin. Biotechnol. 7:343-347[Medline]. |
| 64. |
Thomashow, L. S., and D. M. Weller.
1988.
Role of a phenazine antibiotic from Pseudomonas fluorescens 2-97 in biological control of Gaeumannomyces graminis var. tritici.
J. Bacteriol.
170:3499-3508 |
| 65. | Thomashow, L. S., and D. Weller. 1996. Current concepts in the use of introduced bacteria for biological disease control: mechanisms and antifungal metabolites, p. 187-236. In G. Stacey, and N. T. Keen (ed.), Plant-microbe interactions, vol. 1. Chapman & Hall, Ltd., London, United Kingdom. |
| 66. | Wise, M. G., L. Shimkets, and J. V. McArthur. 1995. Genetic structure of a lotic population of Burkholderia (Pseudomonas) cepacia. Appl. Environ. Microbiol. 61:1791-1798[Abstract]. |
| 67. | Yabuuchi, E., Y. Kosako, H. Oyaizu, I. Yano, H. Hotta, Y. Hahimoto, T. Ezaki, and T. Arakawa. 1992. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas group II to the new genus with the type species Burkholderia cepacia Palleroni and Holmes 1981 comb. nov. Microbiol. Immunol. 36:1251-1275[Medline]. |
| 68. | Yadav, N. S., A. Wierzbicki, M. Aegerter, C. Caster, L. Perez-Grau, A. Kinney, W. Hitz, et al. 1993. Cloning of higher plant omega-fatty acid desaturases. Plant Physiol. 103:466-476. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»